Scientific Approach

Intellectual Property

F-star has built a comprehensive IP portfolio around its core technology and product pipeline that includes patents, trademarks and trade secrets.

With over 200 issued patents and more than 60 pending applications to protect F-star’s mAb2 technology and pipeline, our IP portfolio provides exclusivity around both the Fcab and mAb2 technologies and their applications. It also covers Fcab and mAb2 products and their use in the treatment of disease. 

F-star intends to continue to seek additional patent protection relating to its product candidates currently in development and as it develops additional novel mAb2 product candidates.